Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes
Evidence-Based Medicine, 10/07/09
Fonseca V – Metformin did not improve a composite of microvascular and macrovascular disease but reduced macrovascular disease, prevented weight gain, and improved glycaemic control with less insulin in patients with type 2 diabetes.
Related Articles
Lactic Acidosis Associated With Metformin in a Patient With Type 2 Diabetes With No Contraindication
The Endocrinologist, 11/13/09
Relevance Score: 94%
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 93%
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09
Relevance Score: 93%
Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09
Relevance Score: 93%
Study Finds That ONGLYZA (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA When Added To Metformin In Reducing Hemoglobin In Adults With Type 2 Diabetes Mellitus
Bristol Myers-Squibb Company, 10/06/09
Relevance Score: 93%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Resistance training for obese, type 2 diabetic adults: a review of the evidence
Obesity Reviews, 12/15/09
The DAFNE Collaborative. Experiences of developing a nationally delivered evidence-based, quality-assured programme for people with type 1 diabetes
Practical Diabetes International, 12/15/09
Efficacy of insulin lispro in pregnancies complicated with pregestational diabetes mellitus
Practical Diabetes International, 12/15/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/15/09
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/15/09
Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


